STERLING, Ill., Sept. 18, 2023 /PRNewswire/ — Pain is an unwelcome companion for millions of individuals, and it manifests in various forms and stems from numerous causes. What may provide relief to one person might not be effective for another. In recognition of September being National Pain Awareness Month, at-home massager manufacturer Wahl partnered with board-certified anesthesiologist and pain specialist Dr. Anita Gupta to provide tips on how individuals can lead a more pain-free life.
“There are easy, achievable solutions for those living with pain, including many non-medication options,” explains Dr. Gupta. “I have patients who are looking for alternative treatments to avoid over-dependence on medicines like ibuprofen or aspirin, especially if they’ve experienced adverse outcomes related to NSAIDs.” For example, she offers the following natural pain-relief tips for three common ailments:
It is Wahl’s hope that individuals suffering from pain will join them in observing National Pain Awareness Month and take proactive steps towards a more pain-free and enjoyable life. To explore additional pain management tips and tools, please visit WahlUSA.com.
The foregoing does not create a doctor-patient relationship and is not intended to replace any guidance from your own treating physicians.
About Wahl Home Products
Wahl Home Products is a division of Wahl Clipper Corporation, based in Sterling, Ill. For more than 100 years, the company has remained a trusted name and industry leader, manufacturing products for consumer personal care, animal grooming and professional beauty and barber salon trade. For more information, visit WahlUSA.com.
Download Images:
https://cloud.hoffmanyork.com/portal/s/664914090853336985
SOURCE Wahl
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…